Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects

British Journal of Pharmacology

Volumn 165, Issue 4 B, 2012, Pages 1046-1057

  Pilar Cuellar F ^a,b   Vidal, R ^a,b   Pazos, A ^a,b  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

catenin; 5 HT 2A receptor antagonist; behaviour; BrdU; hippocampus; neuroplasticity; neutrophin; SSRI

Indexed keywords

BETA CATENIN; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; BROXURIDINE; FLUOXETINE; KETANSERIN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN HOMOGENATE; BRAIN MEMBRANE; BRAIN NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; DENTATE GYRUS; DORSAL RAPHE NUCLEUS; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESPONSE; FORCED SWIMMING TEST; GENE EXPRESSION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; IMMOBILIZATION; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR DOWN REGULATION; SEROTONINERGIC SYSTEM; TREATMENT DURATION; WESTERN BLOTTING;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BEHAVIOR, ANIMAL; BETA CATENIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; FLUOXETINE; HIPPOCAMPUS; KETANSERIN; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SWIMMING;

EID: 84856332025     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01516.x     Document Type: Article

References (62)

1. Adell A, Castro E, Celada P, Bortolozzi A, Pazos A, Artigas F, (2005). Strategies for producing faster acting antidepressants. Drug Discov Today 10: 578-585. (Pubitemid 40552825)
2. Aghajanian GK, Marek GJ, (2000). Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Brain Res Rev 31: 302-312. (Pubitemid 30136185)
3. Alexander SP, Mathie A, Peters JA, (2011). Guide to receptors and channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
4. Andersson K, Fuxe K, Eneroth P, Härfstrand A, Agnati LF, (1988). Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat. Neuroendocrinology 48: 188-200.
5. Attar-Lévy D, Martinot JL, Blin J, Dao-Castellana MH, Crouzel C, Mazoyer B, et al,. (1999). The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine. Biol Psychiatry 45: 180-186. (Pubitemid 29079448)
6. Bamji SX, Shimazu K, Kimes N, Huelsken J, Birchmeier W, Lu B, et al,. (2003). Role of beta-catenin in synaptic vesicle localization and presynaptic assembly. Neuron 40: 719-731. (Pubitemid 37431033)
7. Campos MM, Fernandes ES, Ferreira J, Santos AR, Calixto JB, (2005). Antidepressant-like effects of Trichilia catigua (Catuaba) extract: evidence for dopaminergic-mediated mechanisms. Psychopharmacology (Berl) 182: 45-53. (Pubitemid 41400860)
8. Castagné V, Porstol RD, Moser P, (2006). Early behavioral screening for antidepressants and anxiolytics. Drug Dev Res 67: 729-742. (Pubitemid 44936496)
9. Castro ME, Diaz A, del Olmo E, Pazos A, (2003). Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Neuropharmacology 44: 93-101. (Pubitemid 36135846)
10. Catafau AM, Searle GE, Bullich S, Gunn RN, Rabiner EA, Herance R, et al,. (2009). Imaging cortical dopamine D(1) receptors using [(11)C]NNC112 and ketanserin blockade of the 5-HT(2A) receptors. J Cereb Blood Flow Metab 30: 985-993.
11. Celada P, Puig M, Amargõs-Bosch M, Adell A, Artigas F, (2004). The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 29: 252-265. (Pubitemid 39185866)
12. Cryan JF, Page ME, Lucki I, (2005a). Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berl) 182: 335-344. (Pubitemid 41464645)
13. Cryan JF, Valentino RJ, Lucki I, (2005b). Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29: 547-569. (Pubitemid 40755456)
14. David MD, Yeramian A, Duñach M, Llovera M, Cantí C, de Herreros AG, et al,. (2008). Signalling by neurotrophins and hepatocyte growth factor regulates axon morphogenesis by differential beta-catenin phosphorylation. J Cell Sci 121: 2718-2730.
15. De Foubert G, Carney SL, Robinson CS, Destexhe EJ, Tomlinson R, Hichs CA, et al,. (2004). Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 128: 597-604. (Pubitemid 39277429)
16. Duman RS, Heninger GR, Nestler EJ, (1997). A molecular and cellular theory of depression. Arch Gen Psychiatry 54: 597-606. (Pubitemid 27306570)
17. Elfving B, Plougmann PH, Müller HK, Mathé AA, Rosenberg R, Wegener G, (2009). Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression. Int J Neuropsychopharmacol 2: 1-10.
18. Gulyás AI, Acsády L, Freund TF, (1999). Structural basis of the cholinergic and serotonergic modulation of GABAergic neurons in the hippocampus. Neurochem Int 34: 359-372. (Pubitemid 29240632)
19. Hoyer D, Hannon JP, Martin GR, (2002). Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71: 533-554. (Pubitemid 34219205)
20. Huang M, Ichiwaka J, Li Z, Dai J, Meltzer HY, (2006). Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex. Psychopharmacology (Berl) 185: 274-281.
21. Jha S, Rajendran R, Fernandes KA, Vaidya VA, (2008). 5-HT2A/2C receptor blockade regulates progenitor cell proliferation in the adult rat hippocampus. Neurosci Lett 441: 210-214.
22. Kam Y, Quaranta V, (2009). Cadherin-bound beta-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between beta-catenin pools. PLoS ONE 4: e4580.
23. Larsen MH, Rosenbrock H, Sams-Dodd F, Mikkelsen JD, (2007). Expression of brain derived neurotrophic factor, activity-regulated cytoskeleton protein mRNA, and enhancement of adult hippocampal neurogenesis in rats after sub-chronic and chronic treatment with the triple monoamine re-uptake inhibitor tesofensine. Eur J Pharmacol 555: 115-121. (Pubitemid 46048797)
24. Lucassen PJ, Heine VM, Muller MB, van der Beek EM, Wiegant VM, De Kloet ER, et al,. (2006). Stress, depression and hippocampal apoptosis. CNS Neurol Disord Drug Targets 5: 531-546. (Pubitemid 44523871)
25. Madsen TM, Newton SS, Eaton ME, Russell DS, Duman RS, (2003). Chronic electroconvulsive seizure up-regulates β-catenin expression in rat hippocampus: role in adult neurogenesis. Biol Psychiatry 54: 1006-1014. (Pubitemid 37415035)
26. Maguschak KA, Ressler KJ, (2008). Beta-catenin is required for memory consolidation. Nat Neurosci 11: 1319-1326.
27. Malberg JE, Eisch AJ, Nestler EJ, Duman RS, (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20: 9104-9110. (Pubitemid 32042912)
28. Marek GJ, Carpenter LL, McDougle CJ, Price LH, (2003). Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology 28: 402-412.
29. Martinowich K, Lu B, (2008). Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33: 73-83. (Pubitemid 350191318)
30. Massou JM, Trichard C, Attar-Levy D, Feline A, Corruble E, Beaufils B, et al,. (1997). Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors. Psychopharmacology (Berl) 133: 99-101. (Pubitemid 27395826)
31. Mostany R, Valdizán EM, Pazos A, (2008). A role for nuclear beta-catenin in SNRI antidepressant-induced hippocampal cell proliferation. Neuropharmacology 55: 18-26.
32. Nelson WJ, Nusse R, (2004). Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483-1487. (Pubitemid 38314410)
33. Nibuya M, Morinobu S, Duman RS, (1995). Regulation of BDNF and TrkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15: 7539-7547.
34. Nishimura W, Yao I, Iida J, Tanaka N, Hata Y, (2002). Interaction of synaptic scaffolding molecule and Beta-catenin. J Neurosci 22: 757-765. (Pubitemid 34141756)
35. Pandey DK, Mahesh R, Kumar AA, Rao VS, Arjun M, Rajkumar R, (2010). A novel 5-HT(2A) receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: approaching early-onset antidepressants. Pharmacol Biochem Behav 94: 363-373.
36. Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Pandey SC, Pesold C, et al,. (2002). Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 159: 419-429. (Pubitemid 34184737)
37. Patapoutian A, Reichardt LF, (2000). Roles of Wnt proteins in neural development and maintenance. Curr Opin Neurobiol 10: 392-399. (Pubitemid 30389308)
38. Patel JG, Bartoszyk GD, Edwards E, Ashby CR Jr, (2004). The highly selective 5-hydroxytryptamine (5-HT)2A receptor antagonist, EMD 281014, significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test. Synapse 52: 73-75. (Pubitemid 38316272)
39. Paxinos G, Watson C, (1998). The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press Inc.: Sydney, Australia.
40. Pazos A, Cortés R, Palacios JM, (1985). Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 346: 231-249. (Pubitemid 16241112)
41. Peddie CJ, Davies HA, Colyer FM, Stewart MG, Rodríguez JJ, (2008). Colocalisation of serotonin2A receptors with the glutamate receptor subunits NR1 and GluR2 in the dentate gyrus: an ultrastructural study of a modulatory role. Exp Neurol 211: 561-573.
42. Rajkumar R, Pandey DK, Mahesh R, Radha R, (2009). 1-(m-Chlorophenyl) piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay. Eur J Pharmacol 608: 32-41.
43. Rantamäki T, Hendolin P, Kankaanpää A, Mijatovic J, Piepponen P, Domenici E, et al,. (2007). Pharmacologically Diverse Antidepressants Rapidly Activate Brain-Derived Neurotrophic Factor Receptor TrkB and Induce Phospholipase-Cγ Signaling Pathways in Mouse Brain. Neuropsychopharmacology 32: 2152-2162. (Pubitemid 47417694)
44. Ressler KJ, Nemeroff CB, (2000). Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 12 (Suppl. 1): 2-19.
45. Rosel P, Arranz B, San L, Vallejo J, Crespo JM, Urretavizcaya M, et al,. (2000). Altered 5-HT(2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victims. Psychiatry Res 99: 173-181.
46. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al,. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809. (Pubitemid 36962615)
47. Schmidt CJ, Sorensen SM, Kehne JH, Carr AA, Palfreyman MG, (1995). The role of 5-HT2A receptors in antipsychotic activity. Life Sci 56: 2209-2222.
48. Serres F, Azorin JM, Valli M, Jeanningros R, (1999). Evidence for an increase in functional platelet 5-HT2A receptors in depressed patients using the new ligand [125I]-DOI. Eur Psychiatry 14: 451-457. (Pubitemid 30022388)
49. Shelton RC, Tollefson GD, Tohen M, Stahl S, Gannon KS, Jacobs TG, et al,. (2001). A novel augmentation strategy for treating resistant major depression. Am J Psychiatry 158: 131-134. (Pubitemid 32047260)
50. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, et al,. (2003). Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54: 70-75. (Pubitemid 36776725)
51. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS, (2002). Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22: 3251-3261. (Pubitemid 35379212)
52. Sim LJ, Xiao R, Childers SR, (1997). In vitro autoradiographic localization of 5-HT1A receptor-activated G-proteins in the rat brain. Brain Res Bull 44: 39-45. (Pubitemid 27375176)
53. Stockmeier CA, Dilley GE, Shapiro LA, Overholser JC, Thompson PA, Meltzer HY, (1997). Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology 16: 162-173. (Pubitemid 27086431)
54. Trajkovska V, Santini MA, Marcussen AB, Thomsen MS, Hansen HH, Mikkelsen JD, et al,. (2009). BDNF downregulates 5-HT(2A) receptor protein levels in hippocampal cultures. Neurochem Int 55: 697-702.
55. Uchida N, Honjo Y, Johnson KR, Wheelock MJ, Takeichi M, (1996). The catenin/cadherin adhesion system is localized in synaptic junctions bordering transmitter release zones. J Cell Biol 135: 767-779. (Pubitemid 26372931)
56. Ulak G, Mutlu O, Tanyeri P, Komsuoglu FI, Akar FY, Erden BF, (2010). Involvement of serotonin receptor subtypes in the antidepressant-like effect of TRIM in the rat forced swimming test. Pharmacol Biochem Behav 95: 308-314.
57. Vaidya VA, Terwilliger RM, Duman RS, (1999). Role of 5-HT2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci Lett 262: 1-4. (Pubitemid 29104944)
58. Wada A, (2009). Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades. J Pharmacol Sci 110: 14-28.
59. Wang RY, Arvanov VL, (1998). M100907, a highly selective 5-HT2A receptor antagonist and a potential atypical antipsychotic drug, facilitates induction of long-term potentiation in area CA1 of the rat hippocampal slice. Brain Res 779: 309-313. (Pubitemid 28039969)
60. Yu X, Malenka RC, (2003). Beta-catenin is critical for dendritic morphogenesis. Nat Neurosci 6: 1169-1177.
61. Zafra F, Castren E, Thoenen H, Lindholm D, (1991). Interplay between glutamate and g-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc Natl Acad Sci U S A 88: 10037-10041. (Pubitemid 21915770)
62. Zetterström TS, Pei Q, Grahame-Smith DG, (1998). Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Brain Res Mol Brain Res 57: 106-110. (Pubitemid 28279566)